Novo Nordisk: FDA says no more Wegovy and Ozempic shortage
The company has invested $6.5 billion this year alone to expand its U.S. manufacturing capacity.
FDA
The company has invested $6.5 billion this year alone to expand its U.S. manufacturing capacity.